3,400 new pharma deals and financings in 2005

27 February 2006

A new study by UK-based Pharmalicensing reports that there were over 3,400 new deals and financings in the pharmaceutical sector for 2005.

Partneringreview 2006 provides an overview of pharmaceutical and biotechnology deals from the whole of 2005. This second edition sees innovative additions including a fuller coverage of Japanese deals and alliances; an M&A chapter; and a new financings volume including grants/awards, private financings, loans, initial public offerings and public placements. In the past year, the Partneringdesk team has collected over 2,600 new deals and added over 830 financings.

The company says that Partneringreview 2006 supports partner identification, highlighting active therapy areas and types of deal activity, and tracks the amount and type of financing investment by lead investors. The report also includes a review of deal making in 2005, and new volume-specific analytical introductions with graphs. Every deal entry includes financial information where disclosed, such as headline values, upfront and milestone payments. For more information, visit: www.pharmalicensing.com/desk.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight